Dr miranda houston tx

Dr miranda houston tx DEFAULT

Leonidas S Miranda

share on 

share on  MEDICARE General Surgery specialist in Houston TX

Dr. Leonidas S Miranda is a General Surgery Specialist in Houston, Texas. He graduated with honors in 1990. Having more than 31 years of diverse experiences, especially in GENERAL SURGERY, Dr. Leonidas S Miranda affiliates with Houston Northwest Medical Center, cooperates with many other doctors and specialists in medical group Specialty Associates Of West Houston, Pllc. Call Dr. Leonidas S Miranda on phone number (832) 353-2500 for more information and advice or to book an appointment.


Full NameLeonidas S Miranda
PECOS ID7719959436
Experience31+ years of diverse experiences
Sole ProprietorNo - He does not own any un-incorporated business by himself.
Accepts Medicare AssignmentHe does accept the payment amount Medicare approves and not to bill you for more than the Medicare deductible and coinsurance.

Education & Training

  • Dr. Leonidas S Miranda attended to a university and then graduated in 1990

NPPES Information

  • NPI #: 1376673244
  • Enumeration Date: Mar 7th, 2007
  • Last Update Date: Sep 11th, 2018
Request for update

Quality Reporting

Participated programs include
  • Medicare Physician Quality Reporting System (PQRS).
  • Medicare Electronic Health Record (EHR).

Dr. Leonidas S Miranda has primarily specialised in General Surgery for over 31 years.

SpecializationLicense NumberIssued State
Allopathic & Osteopathic Physicians / SurgeryFTL 41417Texas
800 Peakwood Dr Ste 5d
Houston, Texas 77090-2903
Map and Directions
Phone: (832) 353-2500
Fax: (281) 880-9483

Office Hours:
  • Monday - Friday: 8:00 AM - 5:00 PM
  • Saturday - Sunday: Closed

This doctor profile was extracted from the dataset publicized on Sep 25th, 2021 by the Centers for Medicare and Medicaid Services (CMS) and from the corresponded NPI record updated on Sep 11th, 2018 on NPPES website. If you found out anything that is incorrect and want to change it, please follow this Update Data guide.

Related Doctors and Physicians

Sours: https://www.healthcare4ppl.com/physician/texas/houston/leonidas-s-miranda-1376673244.html

Roberto N. Miranda, M.D.

Department of Hematopathology, Division of Pathology-Lab Medicine Div

Primary Appointment

Professor, Department of Hematopathology, Division of Pathology/Lab Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX

Degree-Granting Education

1983Universidad Peruana Cayetano Heredia, Lima, PER, MD, Medicine

Peer-Reviewed Articles

  1. Beltran BE, Quiñones P, Sanchez G, Paredes A, Moises C, Cotrina E, Torres-Cabala CA, Miranda RN, Castillo JJ. Primary cutaneous plasmablastic lymphoma in an immunocompetent patient: is it associated with an indolent course?. Leuk Lymphoma 59(7):1-3, 2018. e-Pub 2017. PMID: 29081245.
  2. Sun Y, Tang G, Hu Z, Thakral B, Miranda RN, Medeiros LJ, Wang SA. Comparison of karyotyping, TCL1 fluorescence in situ hybridisation and TCL1 immunohistochemistry in T cell prolymphocytic leukaemia. J Clin Pathol 71(4):309-315, 2018. e-Pub 2017. PMID: 28821581.
  3. Hosry J, Miranda RN, Samaniego F, Economides MP, Torres HA. Clinicopathologic characteristics and outcomes of transformed diffuse large B-cell lymphoma in hepatitis C virus-infected patients. Int J Cancer 142(5):940-948, 2018. e-Pub 2017. PMID: 29047108.
  4. Ferrufino-Schmidt MC, Medeiros LJ, Liu H, Clemens MW, Hunt KK, Laurent C, Lofts J, Amin MB, Ming Chai S, Morine A, Di Napoli A, Dogan A, Parkash V, Bhagat G, Tritz D, Quesada AE, Pina-Oviedo S, Hu Q, Garcia-Gomez FJ, Jose Borrero J, Horna P, Thakral B, Narbaitz M, Hughes RC, Yang LJ, Fromm JR, Wu D, Zhang D, Sohani AR, Hunt J, Vadlamani IU, Morgan EA, Ferry JA, Szigeti R, C Tardio J, Granados R, Dertinger S, Offner FA, Pircher A, Hosry J, Young KH, Miranda RN. Clinicopathologic Features and Prognostic Impact of Lymph Node Involvement in Patients With Breast Implant-associated Anaplastic Large Cell Lymphoma. Am J Surg Pathol 42(3):293-305, 2018. e-Pub 2017. PMID: 29194092.
  5. Hu Z, Sun Y, Schlette EJ, Tang G, Li S, Xu J, Yin CC, Young KH, Patel KP, Miranda RN, Goswami M, Wang M, Jorgensen JL, Medeiros LJ, Wang SA. CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course. Mod Pathol 31(2):327-336, 2018. e-Pub 2017. PMID: 28984300.
  6. Pina-Oviedo S, Miranda RN, Medeiros LJ. Cancer Therapy-associated Lymphoproliferative Disorders: An Under-Recognized Type of Immunodeficiency-associated Lymphoproliferative Disorder. Am J Surg Pathol 42(1):116-129, 2018. e-Pub 2017. PMID: 29112013.
  7. Quesada AE, Medeiros LJ, Desai PA, Lin P, Westin JR, Hawsawi HM, Wei P, Tang G, Seegmiller AC, Reddy NM, Yin CC, Wang W, Xu J, Miranda RN, Zuo Z, Li S. Increased MYC copy number is an independent prognostic factor in patients with diffuse large B-cell lymphoma. Mod Pathol 30(12):1688-1697, 2017. e-Pub 2017. PMID: 28776574.
  8. Chihara D, Westin JR, Miranda RN, Cheah CY, Oki Y, Turturro F, Romaguera JE, Neelapu SS, Nastoupil LJ, Fayad LE, Rodriguez MA, Fowler NH, Orlowski RZ, Wang M, Hagemeister FB, Medeiros LJ, Fanale MA. Dose adjusted-EPOCH-R and mediastinal disease may improve outcomes for patients with gray-zone lymphoma. Br J Haematol 179(3):503-506, 2017. e-Pub 2016. PMID: 27378601.
  9. Yuan T, Yang Y, Chen J, Li W, Li W, Zhang Q, Mi Y, Goswami RS, You JQ, Lin D, Qian MD, Calin S, Liang Y, Miranda RN, Calin GA, Zhou X, Ma L, Zweidler-McKay PA, Liu B, Weng AP, Medeiros LJ, Zhang Y, You MJ. Regulation of PI3K signaling in T-cell acute lymphoblastic leukemia: a novel PTEN/Ikaros/miR-26b mechanism reveals a critical targetable role for PIK3CD. Leukemia 31(11):2355-2364, 2017. e-Pub 2017. PMID: 28280276.
  10. Pina-Oviedo S, Miranda RN, Lin P, Manning JT, Medeiros LJ. Follicular lymphoma with hyaline-vascular Castleman-like features: analysis of 6 cases and review of the literature. Hum Pathol 68:136-146, 2017. e-Pub 2017. PMID: 28873356.
  11. Li X, Xu-Monette ZY, Yi S, Dabaja BS, Manyam GC, Westin J, Fowler N, Miranda RN, Zhang M, Ferry JA, Medeiros LJ, Harris NL, Young KH. Primary Bone Lymphoma Exhibits a Favorable Prognosis and Distinct Gene Expression Signatures Resembling Diffuse Large B-Cell Lymphoma Derived From Centrocytes in the Germinal Center. Am J Surg Pathol 41(10):1309-1321, 2017. PMID: 28817403.
  12. Cuglievan B, Menegaz BA, DePombo A, Morani AC, Miranda RN, Rytting M. A pediatric patient with glycogen storage disease type IA and Castleman disease. Pediatr Blood Cancer 64(8), 2017. e-Pub 2016. PMID: 28035790.
  13. Zhang H, Chen Z, Miranda RN, Medeiros LJ, McCarty N. Bifurcated BACH2 control coordinates mantle cell lymphoma survival and dispersal during hypoxia. Blood 130(6):763-776, 2017. e-Pub 2017. PMID: 28592433.
  14. Montenegro-Garreaud X, Miranda RN, Reynolds A, Tang G, Wang SA, Yabe M, Wang W, Fang L, Bueso-Ramos CE, Lin P, Medeiros LJ, Lu X. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase. Hum Pathol 65:147-156, 2017. e-Pub 2017. PMID: 28551329.
  15. Hidalgo-López JE, Kanagal-Shamanna R, Medeiros LJ, Estrov Z, Yin CC, Verstovsek S, Konoplev S, Jorgensen JL, Mohammad MM, Miranda RN, Zhao C, Lee J, Zuo Z, Bueso-Ramos CE. Morphologic and Molecular Characteristics of De Novo AML With JAK2 V617F Mutation. J Natl Compr Canc Netw 15(6):790-796, 2017. PMID: 28596259.
  16. Pina-Oviedo S, Torres-Cabala CA, Miranda RN, Tetzlaff MT, Singh S, Rapini RP, Prieto VG, Aung PP. Concomitant Cutaneous Langerhans Cell Hystiocytosis and Leukemia Cutis. Am J Dermatopathol 39(5):388-392, 2017. PMID: 27759701.
  17. Doren EL, Miranda RN, Selber JC, Garvey PB, Liu J, Medeiros LJ, Butler CE, Clemens MW. U.S. Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Plast Reconstr Surg 139(5):1042-1050, 2017. PMID: 28157769.
  18. Clemens MW, Nava MB, Rocco N, Miranda RN. Understanding rare adverse sequelae of breast implants: anaplastic large-cell lymphoma, late seromas, and double capsules. Gland Surg 6(2):169-184, 2017. PMID: 28497021.
  19. Agbay RL, Torres-Cabala CA, Patel KP, Merril ED, Duvic M, Quesada A, Prieto VG, Aung PP, Loghavi S, Young KH, Hu S, Ferrufino-Schmidt MC, Tetzlaff M, Li S, Medeiros LJ, Miranda RN. Immunophenotypic Shifts in Primary Cutaneous γδ T-Cell Lymphoma Suggest Antigenic Modulation: A Study of Sequential Biopsy Specimens. Am J Surg Pathol 41(4):431-445, 2017. PMID: 28248813.
  20. Xia Y, Xu-Monette ZY, Tzankov A, Li X, Manyam GC, Murty V, Bhagat G, Zhang S, Pasqualucci L, Visco C, Dybkaer K, Chiu A, Orazi A, Zu Y, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J, Ponzoni M, Ferreri AJ, Møller MB, Parsons BM, Winter JN, Piris MA, Westin J, Fowler N, Miranda RN, Ok CY, Li Y, Li J, Medeiros LJ, Young KH. Loss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma. Leukemia 31(3):625-636, 2017. e-Pub 2016. PMID: 27568520.
  21. Chihara D, Fanale MA, Miranda RN, Noorani M, Westin JR, Nastoupil LJ, Hagemeister FB, Fayad LE, Romaguera JE, Samaniego F, Turturro F, Lee HJ, Neelapu SS, Rodriguez MA, Wang M, Fowler NH, Davis RE, Medeiros LJ, Hosing C, Nieto YL, Oki Y. The survival outcome of patients with relapsed/refractory peripheral T-cell lymphoma-not otherwise specified and angioimmunoblastic T-cell lymphoma. Br J Haematol 176(5):750-758, 2017. e-Pub 2016. PMID: 27983760.
  22. Yu L, Tu M, Cortes J, Xu-Monette ZY, Miranda RN, Zhang J, Orlowski RZ, Neelapu S, Boddu PC, Akosile MA, Uldrick TS, Yarchoan R, Medeiros LJ, Li Y, Fajgenbaum DC, Young KH. Clinical and pathological characteristics of HIV- and HHV-8-negative Castleman disease. Blood 129(12):1658-1668, 2017. e-Pub 2017. PMID: 28100459.
  23. Wang XJ, Jeffrey Medeiros L, Bueso-Ramos CE, Tang G, Wang S, Oki Y, Desai P, Khoury JD, Miranda RN, Tang Z, Reddy N, Li S. P53 expression correlates with poorer survival and augments the negative prognostic effect of MYC rearrangement, expression or concurrent MYC/BCL2 expression in diffuse large B-cell lymphoma. Mod Pathol 30(2):194-203, 2017. e-Pub 2016. PMID: 27739436.
  24. Yabe M, Medeiros LJ, Daneshbod Y, Davanlou M, Bueso-Ramos CE, Moran EJ, Young KH, Miranda RN. Hepatosplenic T-cell lymphoma arising in patients with immunodysregulatory disorders: a study of 7 patients who did not receive tumor necrosis factor-α inhibitor therapy and literature review. Ann Diagn Pathol 26:16-22, 2017. e-Pub 2016. PMID: 28038706.
  25. Merrill ED, Agbay R, Miranda RN, Aung PP, Tetzlaff MT, Young KH, Curry JL, Nagarajan P, Ivan D, Prieto VG, Medeiros LJ, Duvic M, Torres-Cabala CA. Primary Cutaneous T-Cell Lymphomas Showing Gamma-Delta (γδ) Phenotype and Predominantly Epidermotropic Pattern are Clinicopathologically Distinct From Classic Primary Cutaneous γδ T-Cell Lymphomas. Am J Surg Pathol 41(2):204-215, 2017. PMID: 27879514.
  26. Yabe M, Medeiros LJ, Wang SA, Tang G, Bueso-Ramos CE, Jorgensen JL, Bhagat G, Chen W, Li S, Young KH, Miranda RN. Distinguishing Between Hepatosplenic T-cell Lymphoma and γδ T-cell Large Granular Lymphocytic Leukemia: A Clinicopathologic, Immunophenotypic, and Molecular Analysis. Am J Surg Pathol 41(1):82-93, 2017. e-Pub 2016. PMID: 27755009.
  27. Hosry J, Mahale P, Turturro F, Miranda RN, Economides MP, Granwehr BP, Torres HA. Antiviral therapy improves overall survival in hepatitis C virus-infected patients who develop diffuse large B-cell lymphoma. Int J Cancer 139(11):2519-28, 2016. e-Pub 2016. PMID: 27501007.
  28. Loghavi S, Wang SA, Jeffrey Medeiros L, Jorgensen JL, Li X, Xu-Monette ZY, Miranda RN, Young KH. Immunophenotypic and diagnostic characterization of angioimmunoblastic T-cell lymphoma by advanced flow cytometric technology. Leuk Lymphoma 57(12):2804-2812, 2016. e-Pub 2016. PMID: 27105079.
  29. Al-Rohil RN, Torres-Cabala CA, Patel A, Tetzlaff MT, Ivan D, Nagarajan P, Curry JL, Miranda RN, Duvic M, Prieto VG, Aung PP. Loss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphoma: a novel finding. J Cutan Pathol 43(12):1161-1166, 2016. e-Pub 2016. PMID: 27531242.
  30. Dy-Ledesma JL, Khoury JD, Agbay RL, Garcia M, Miranda RN, Medeiros LJ. Starry Sky Pattern in Hematopoietic Neoplasms: A Review of Pathophysiology and Differential Diagnosis. Adv Anat Pathol 23(6):343-355, 2016. PMID: 27677083.
  31. Zhang H, Chen Z, Miranda RN, Medeiros LJ, McCarty N. TG2 and NF-kB signaling coordinates the survival of mantle cell lymphoma cells via IL-6-mediated autophagy. Cancer Res 76(21):6410-6423, 2016. e-Pub 2016. PMID: 27488529.
  32. Ramani NS, Curry JL, Merrill ED, Aung PP, Prieto V, Tetzlaff MT, Duvic M, Miranda R, Torres-Cabala C. Primary Cutaneous Gamma-Delta (γ/δ) T-cell Lymphoma: An Unusual Case With Very Subtle Histopathological Findings. Am J Dermatopathol 38(10):e147-9, 2016. PMID: 27533072.
  33. Quesada AE, Liu H, Miranda RN, Golardi N, Billah S, Medeiros LJ, Jaso JM. Burkitt lymphoma presenting as a mass in the thyroid gland: a clinicopathologic study of 7 cases and review of the literature. Hum Pathol 56:101-8, 2016. e-Pub 2016. PMID: 27257042.
  34. Huang L, Wang SA, Konoplev S, Bueso-Ramos CE, Thakral B, Miranda RN, Jabbour E, Medeiros LJ, Kanagal-Shamanna R. Well-differentiated systemic mastocytosis showed excellent clinical response to imatinib in the absence of known molecular genetic abnormalities: A case report. Medicine (Baltimore) 95(41):e4934, 2016. PMID: 27741105.
  35. Hidalgo Lopez JE, Yabe M, Carballo-Zarate AA, Wang SA, Jorgensen JL, Ahmed S, Lee J, Li S, Schlette E, McDonnell T, Miranda RN, Medeiros LJ, Bueso-Ramos CE, Yin CC. Donor-Derived T-Cell Large Granular Lymphocytic Leukemia in a Patient With Peripheral T-Cell Lymphoma. J Natl Compr Canc Netw 14(8):939-44, 2016. PMID: 27496109.
  36. Sasaki K, Popat U, Jain P, Kadia T, Patel K, Patel K, Jain N, Takahashi K, Young K, Miranda RN, Oo TH, Lu H, Pemmaraju N. Successful treatment of aplastic anemia-paroxysmal nocturnal hemoglobinuria associated with eosinophilic fasciitis with matched unrelated donor allogeneic peripheral blood stem cell transplantation. Clin Case Rep 4(8):765-7, 2016. e-Pub 2016. PMID: 27525080.
  37. Xu-Monette ZY, Deng Q, Manyam GC, Tzankov A, Li L, Xia Y, Wang XX, Zou D, Visco C, Dybkær K, Li J, Zhang L, Liang H, Montes-Moreno S, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J, Ponzoni M, Ferreri AJ, Parsons BM, Møller MB, Wang SA, Miranda RN, Piris MA, Winter JN, Medeiros LJ, Li Y, Young KH. Clinical and Biologic Significance of MYC Genetic Mutations in De Novo Diffuse Large B-cell Lymphoma. Clin Cancer Res 22(14):3593-605, 2016. e-Pub 2016. PMID: 26927665.
  38. Wang W, Tang G, Kadia T, Lu X, Li Y, Huang L, Montenegro-Garreaud X, Miranda RN, Wang SA. Cytogenetic Evolution Associated With Disease Progression in Hematopoietic Neoplasms With t(8;22)(p11;q11)/BCR-FGFR1 Rearrangement. J Natl Compr Canc Netw 14(6):708-11, 2016. PMID: 27283163.
  39. Li S, Saksena A, Desai P, Xu J, Zuo Z, Lin P, Tang G, Yin CC, Seegmiller A, Jorgensen JL, Miranda RN, Reddy NM, Bueso-Ramos C, Medeiros LJ. Prognostic impact of history of follicular lymphoma, induction regimen and stem cell transplant in patients with MYC/BCL2 double hit lymphoma. Oncotarget 7(25):38122-38132, 2016. e-Pub 2016. PMID: 27203548.
  40. Cao X, Medeiros LJ, Xia Y, Wang X, Thomas SK, Loghavi S, Li X, Shah JJ, Gustafson SA, Weber DM, Miranda RN, Xu-Monette ZY, Orlowski RZ, Young KH. Clinicopathologic Features and Outcomes of Lymphoplasmacytic Lymphoma Patients with Monoclonal IgG or IgA Paraprotein Expression. Leuk Lymphoma 57(5):1-27, 2016. e-Pub 2015. PMID: 26421453.
  41. Chen Z, Wang W, Cortes JE, Liu E, Miranda RN, Zhao C, Yuan J, Lu X, Yang W, Ameri MD, Kantarjian HM, Medeiros LJ, Hu S. Differential clinical and prognostic impact of myeloid sarcoma vs medullary myeloid blast phase of chronic myelogenous leukemia in the era of tyrosine kinase inhibitor therapy. Blood Cancer J 6:e418, 2016. e-Pub 2016. PMID: 27152845.
  42. Castillo JJ, Beltran BE, Miranda RN, Young KH, Chavez JC, Sotomayor EM. EBV-positive diffuse large B-cell lymphoma of the elderly: 2016 update on diagnosis, risk-stratification, and management. Am J Hematol 91(5):529-37, 2016. PMID: 27093913.
  43. Yabe M, Medeiros LJ, Tang G, Wang SA, Ahmed S, Nieto Y, Hu S, Bhagat G, Oki Y, Patel KP, Routbort M, Luthra R, Fanale MA, Bueso-Ramos CE, Jorgensen JL, Vega F, Chen W, Hoehn D, Konoplev S, Milton DR, Wistuba I, Li S, You MJ, Young KH, Miranda RN. Prognostic Factors of Hepatosplenic T-cell Lymphoma: Clinicopathologic Study of 28 Cases. Am J Surg Pathol 40(5):676-88, 2016. PMID: 26872013.
  44. Clemens MW, Miranda RN, Butler CE. Breast Implant Informed Consent Should Include the Risk of Anaplastic Large Cell Lymphoma. Plast Reconstr Surg 137(4):1117-22, 2016. PMID: 27018666.
  45. Yabe M, Medeiros LJ, Tang G, Wang SA, P Patel K, Routbort M, Bhagat G, Bueso-Ramos CE, Jorgensen JL, Luthra R, Chen W, Muzzafar T, Kanagal-Shamanna R, Khoury JD, Daneshbod Y, Davanlou M, Li S, Young KH, Miranda RN. Dyspoietic changes associated with hepatosplenic T-cell lymphoma are not a manifestation of a myelodysplastic syndrome: analysis of 25 patients. Hum Pathol 50:109-17, 2016. e-Pub 2015. PMID: 26997444.
  46. Kanagal-Shamanna R, Xu-Monette ZY, Miranda RN, Dogan A, Zou D, Luthra R, Weber DM, O'Malley DP, Jorgensen JL, Khoury JD, Bueso-Ramos CE, Orlowski RZ, Medeiros LJ, Young KH. Crystal-storing histiocytosis: a clinicopathological study of 13 cases. Histopathology 68(4):482-91, 2016. PMID: 26118455.
  47. Teo AE, Chen Z, Miranda RN, McDonnell T, Medeiros LJ, McCarty N. Differential PAX5 levels promote malignant B-cell infiltration, progression and drug resistance, and predict a poor prognosis in MCL patients independent of CCND1. Leukemia 30(3):580-93, 2016. e-Pub 2015. PMID: 26073757.
  48. Wang W, Ali S, Tang Z, Miranda RN, Yang S, Medeiros LJ, Hu S. Constitutional pericentric inversion of chromosome 9 has no impact on survival in chronic myelogenous leukemia. Ann Hematol 95(4):657-9, 2016. e-Pub 2016. PMID: 26758271.
  49. Ishizawa J, Kojima K, Chachad D, Ruvolo P, Ruvolo V, Jacamo RO, Borthakur G, Mu H, Zeng Z, Tabe Y, Allen JE, Wang Z, Ma W, Lee HC, Orlowski R, Sarbassov dos D, Lorenzi PL, Huang X, Neelapu SS, McDonnell T, Miranda RN, Wang M, Kantarjian H, Konopleva M, Davis RE, Andreeff M. ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies. Sci Signal 9(415):ra17, 2016. e-Pub 2016. PMID: 26884599.
  50. Clemens MW, Medeiros LJ, Butler CE, Hunt KK, Fanale MA, Horwitz S, Weisenburger DD, Liu J, Morgan EA, Kanagal-Shamanna R, Parkash V, Ning J, Sohani AR, Ferry JA, Mehta-Shah N, Dogan A, Liu H, Thormann N, Di Napoli A, DiNapoli A, Lade S, Piccolini J, Reyes R, Williams T, McCarthy CM, Hanson SE, Nastoupil LJ, Gaur R, Oki Y, Young KH, Miranda RN. Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant-Associated Anaplastic Large-Cell Lymphoma. J Clin Oncol 34(2):160-8, 2016. PMID: 26628470.
  51. Bassuner J, Miranda RN, Emge DA, DiCicco BA, Lewis DJ, Duvic M. Mycosis Fungoides of the Oral Cavity: Fungating Tumor Successfully Treated with Electron Beam Radiation and Maintenance Bexarotene. Case Rep Dermatol Med 2016:5857935, 2016. e-Pub 2016. PMID: 28074163.
  52. Xu-Monette ZY, Dabaja BS, Wang X, Tu M, Manyam GC, Tzankov A, Xia Y, Zhang L, Sun R, Visco C, Dybkaer K, Yin L, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J, Ponzoni M, Ferreri AJ, Møller MB, Parsons BM, Zhao X, Winter JN, Piris MA, McDonnell TJ, Miranda RN, Li Y, Medeiros LJ, Young KH. Clinical features, tumor biology, and prognosis associated with MYC rearrangement and Myc overexpression in diffuse large B-cell lymphoma patients treated with rituximab-CHOP. Mod Pathol 28:1555-73, 2015. e-Pub 2015. PMID: 26541272.
  53. Yabe M, Medeiros LJ, Wang SA, Konoplev S, Ok CY, Loghavi S, Lu G, Flores L, Khoury JD, Cason RC, Young KH, Miranda RN. Clinicopathologic, Immunophenotypic, Cytogenetic, and Molecular Features of γδ T-Cell Large Granular Lymphocytic Leukemia: An Analysis of 14 Patients Suggests Biologic Differences With αβ T-Cell Large Granular Lymphocytic Leukemia. Am J Clin Pathol 144:607-19, 2015. PMID: 26386082.
  54. Yabe M, Tang G, Garcia-Manero G, Loghavi S, Lu X, Miranda RN, Medeiros LJ, Kantarjian HM, Bueso-Ramos CE, Khoury JD. Acute Myeloid Leukemia With t(v;5q33) Is Associated With Poor Overall Survival and Often Lacks Myelodysplastic Features. Clin Lymphoma Myeloma Leuk 15 Suppl:S85-90, 2015. PMID: 26297286.
  55. Xu-Monette ZY, Tu M, Jabbar KJ, Cao X, Tzankov A, Visco C, Cai Q, Montes-Moreno S, An Y, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J, Ponzoni M, Ferreri AJ, Zhao X, Møller MB, Farnen JP, Winter JN, Piris MA, Miranda RN, Medeiros LJ, Young KH. Clinical and biological significance of de novo CD5+ diffuse large B-cell lymphoma in western countries. Oncotarget 6:5615-33, 2015. e-Pub 2015. PMID: 25760242.
  56. Li S, Seegmiller AC, Lin P, Wang XJ, Miranda RN, Bhagavathi S, Medeiros LJ. B-Cell Lymphomas with Concurrent MYC and BCL2 Abnormalities Other than Translocations Behave Similarly to MYC/BCL2 Double-Hit Lymphomas. Mod Pathol 28:208-17, 2015. PMID: 25103070.
  57. Aguilar C, Beltran B, Quiñones P, Carbajal T, Vilcapaza J, Yabar A, Segura P, Quintanilla-Martinez L, Miranda RN, Castillo JJ. Large B-cell lymphoma arising in cardiac myxoma or intracardiac fibrinous mass: a localized lymphoma usually associated with Epstein-Barr virus?. Cardiovasc Pathol 24:60-4, 2015. PMID: 25307939.
  58. Torres-Cabala CA, Curry JL, Li Ning Tapia EM, Ramos C, Tetzlaff MT, Prieto VG, Miranda RN, Bravo F. HTLV-1-associated infective dermatitis demonstrates low frequency of FOXP3-positive T-regulatory lymphocytes. J Dermatol Sci 77:150-5, 2015. PMID: 25676425.
  59. Castillo JJ, Bibas M, Miranda RN. The biology and treatment of plasmablastic lymphoma. Blood 125:2323-30, 2015. PMID: 25636338.
  60. Loghavi S, Alayed K, Aladily TN, Zuo Z, Ng SB, Tang G, Hu S, Yin CC, Miranda RN, Medeiros LJ, Khoury JD. Stage, age, and EBV status impact outcomes of plasmablastic lymphoma patients: a clinicopathologic analysis of 61 patients. J Hematol Oncol 8:65, 2015. e-Pub 2015. PMID: 26055271.
  61. Cao X, Ye Q, Orlowski RZ, Wang X, Loghavi S, Tu M, Thomas SK, Shan J, Li S, Qazilbash M, Yin CC, Weber D, Miranda RN, Xu-Monette ZY, Medeiros LJ, Young KH. Waldenström macroglobulinemia with extramedullary involvement at initial diagnosis portends a poorer prognosis. J Hematol Oncol 8:74, 2015. PMID: 26104577.
  62. Mehrotra M, Patel KP, Chen T, Miranda RN, Wang Y, Zuo Z, Muddasani R, Mishra BM, Abraham R, Luthra R, Lu G. Genomic and Clinicopathologic Features of Primary Myelofibrosis With Isolated 13q Deletion. Clin Lymphoma Myeloma Leuk 15:496-505.e2, 2015. PMID: 26027540.
  63. Chihara D, Pro B, Loghavi S, Miranda RN, Medeiros LJ, Fanale MA, Hagemeister FB, Fayad LE, Romaguera JE, Samaniego F, Neelapu SS, Younes A, Fowler NH, Rodriguez MA, Wang M, Kwak LW, McLaughlin P, Dang NH, Oki Y. Phase II study of HCVIDD/MA in patients with newly diagnosed peripheral T-cell lymphoma. Br J Haematol 171:509-16, 2015. PMID: 26260306.
  64. Vega F, Medeiros LJ, Bueso-Ramos CE, Arboleda P, Miranda RN. Hematolymphoid Neoplasms Associated With Rearrangements of PDGFRA, PDGFRB, and FGFR1. Am J Clin Pathol 144:377-92, 2015. PMID: 26276769.
  65. Loghavi S, Al-Ibraheemi A, Zuo Z, Garcia-Manero G, Yabe M, Wang SA, Kantarjian HM, Yin CC, Miranda RN, Luthra R, Medeiros LJ, Bueso-Ramos CE, Khoury JD. TP53 overexpression is an independent adverse prognostic factor in de novo myelodysplastic syndromes with fibrosis. Br J Haematol 171:91-9, 2015. e-Pub 2015. PMID: 26123119.
  66. Kiel MJ, Sahasrabuddhe AA, Rolland DC, Velusamy T, Chung F, Schaller M, Bailey NG, Betz BL, Miranda RN, Porcu P, Byrd JC, Jeffrey Medeiros L, Kunkel SL, Bahler DW, Lim MS, Elenitoba-Johnson KS. Genomic analyses reveal recurrent mutations in epigenetic modifiers and the JAK-STAT pathway in Sézary syndrome. Nat Commun 6:8470, 2015. e-Pub 2015. PMID: 26415585.
  67. Clemens MW, Miranda RN. Coming of Age: Breast Implant-Associated Anaplastic Large Cell Lymphoma After 18 Years of Investigation. Clin Plast Surg 42:605-13, 2015. PMID: 26408447.
  68. Zhang S, Lu Z, Mao W, Ahmed AA, Yang H, Zhou J, Jennings N, Rodriguez-Aguayo C, Lopez-Berestein G, Miranda R, Qiao W, Baladandayuthapani V, Li Z, Sood AK, Liu J, Le XF, Bast RC. CDK5 Regulates Paclitaxel Sensitivity in Ovarian Cancer Cells by Modulating AKT Activation, p21Cip1- and p27Kip1-Mediated G1 Cell Cycle Arrest and Apoptosis. PLoS One 10:e0131833, 2015. e-Pub 2015. PMID: 26146988.
  69. O'Malley DP, Louissant A Jr, Vasef MA, Auerbach A, Miranda R, Brynes RK, Fedoriw Y, hudnall SD, International Spleen Consortium. Recommendations for Gross Examinations and Sampling of Surgical specimens of the Spleen. Ann Diagn Pathol 19:288-95, 2015.
  70. Beltrán BE, Maza I, Moisés-Alfaro CB, Vasquez L, Quiñones P, Morales D, Sánchez G, Paredes G, Oscanoa M, Gerónimo J, Miranda RN, Castillo JJ. Thalidomide for the treatment of hydroa vacciniforme-like lymphoma: Report of four pediatric cases from Peru. Am J Hematol 89:1160-1, 2014. e-Pub 2014. PMID: 25196949.
  71. Zhang L, Singh RR, Patel KP, Stingo F, Routbort M, James You M, Miranda RN, Garcia-Manero G, Kantarjian HM, Jeffrey Medeiros L, Luthra R, Khoury JD. BRAF kinase domain mutations are present in a subset of chronic myelomonocytic leukemia with wild-type RAS. Am J Hematol 89:499-504, 2014. PMID: 24446311.
  72. Ok CY, Yin CC, Yabe M, Bueso-Ramos CE, Miranda RN, Medeiros LJ, Konoplev S.. Lymphoma with features intermediate between aggressive T-large granular lymphocytic leukemia and hepatosplenic T-cell lymphoma: A diagnostic dilema?. Clinical Lymphoma, Myeloma & Leukemia 14:95-100, 2014. PMID: 24524924.
  73. Kiel MJ, Velusamy T, Rolland D, Sahasrabuddhe AA, Chung F, Bailey NG, Schrader A, Li B, Li JZ, Ozel AB, Betz BL, Miranda RN, Medeiros LJ, Zhao L, Herling M, Lim MS, Elenitoba-Johnson KS.. Integrated genomic sequencing reveals mutational landscape of T-cell prolymphocytic leukemia. Blood 124:1460-72, 2014. e-Pub 2014. PMID: 24825865.
  74. Benveniste AP, Marom E, Benveniste M, Mawlawi O, Miranda RN, Yang W.. Metastases to the breast from extramammary malignancies-PET/CT findings. Eur J Radiol 83:1106-12, 2014.
  75. Wang S, Medeiros LJ, Xu-Monette Z, Zhang S, O'Malley D, Orazi A, Zuo Z, Bueso-Ramos C, Yin C, Zhiyu L, Miranda RN, Young KH.. Epstein-Barr virus-positive nodular lymphocyte predominant Hodgkin lymphoma. Ann Diag Pathol 18:203-09, 2014.
  76. Challagundla P, Medeiros LJ, Kanagal-Shamanna R, Miranda RN, Jorgensen JL.. Differential Expression of CD200 in B-cell Neoplasms by Flow Cytometry Can Assist in Diagnosis, Subclassification, and Bone Marrow Staging. Am J Clin Pathol 142:837-44, 2014.
  77. Velusamy T, Kiel MJ, Sahasrabuddhe AA, Rolland D, Dixon CA, Bailey NG, Betz BL, Brown NA, Hristov AC, Wilcox RA, Miranda RN, Medeiros LJ, Jeon YK, Inamdar KV, Lim MS, Elenitoba-Johnson KS. A novel recurrent NPM1-TYK2 gene fusion in cutaneous CD30-positive lymphoproliferative disorders. Blood 124:3768-71, 2014. PMID: 25349176.
  78. Beltrán BE, Castillo JJ, Quiñones P, Morales D, Paredes A, Nieto G, Miranda RN, Torres-Cabala CA. Extranodal marginal zone lymphoma from ocular adnexae with subcutaneous involvement. Am J Dermatopathol 36:e189-93, 2014. PMID: 25238445.
  79. Adrada BE, Miranda RN, Rauch GM, Arribas E, Kanagal-Shamanna R, Clemens MW, Fanale M, Haideri N, Mustafa E, Larrinaga J, Reisman NR, Jaso J, You MJ, Young KH, Medeiros LJ, Yang W.. Breast implant-associated anaplastic large cell lymphoma: sensitivity, specificity, and findings of imaging studies in 44 patients. Breast Cancer Res Trea 147:1-14, 2014.
  80. Ok CY, Li L, Xu-Monette ZY, Visco C, Tzankov A, Manyam GC, Montes-Moreno S, Dybaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Chen J, Richards KL, Hsi ED, Choi WW, van Krieken JH, Huh J, Ai W, Ponzoni M, Ferreri AJ, Farnen JP, Møller MB, Bueso-Ramos CE, Miranda RN, Winter JN, Piris MA, Medeiros LJ, Young KH.. Prevalence and Clinical Implications of Epstein-Barr Virus Infection in De Novo Diffuse Large B-Cell Lymphoma in Western Countries. Clin Cancer Res 20:2338-49, 2014. PMID: 24583797.
  81. Jabbar KJ, Medeiros LJ, Wang SA, Miranda RN, Johnson MR, Verstovsek S, Jorgensen JL.. Flow cytometric immunophenotypic analysis of systemic mastocytosis involving bone marrow. Arch Pathol Lab Med 138:1210-14, 2014.
  82. Miranda RN, Aladily TN, Prince HM, Kanagal-Shamanna R, de Jong D, Fayad LE, Amin MB, Haideri N, Bhagat G, Brooks GS, Shifrin DA, O'Malley DP, Cheah CY, Bacchi CE, Gualco G, Li S, Keech JA, Hochberg EP, Carty MJ, Hanson SE, Mustafa E, Sanchez S, Manning JT, Xu-Monette ZY, Miranda AR, Fox P, Bassett RL, Castillo JJ, Beltran BE, de Boer JP, Chakhachiro Z, Ye D, Clark D, Young KH, Medeiros LJ. Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients. J Clin Oncol 10:114-20, 2014. e-Pub 2013. PMID: 24323027.
  83. Challagundla P, Jorgensen JL, Kanagal-Shamanna R, Gurevich I, Pierson DM, Ferrajoli A, Reyes SR, Medeiros LJ, Miranda RN.. Utility of Quantitative Flow Cytometry Immunophenotypic Analysis of CD5 Expression in Small B-cell Neoplasms. Arch Pathol Lab Med 138:903-09, 2014.
  84. Hu S, Xu-Monette ZY, Balasubramanyam A, Manyam GC, Visco C, Tzankov A, Liu WM, Miranda RN, Zhang L, Montes-Moreno S, Dybkær K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, Han van Krieken J, Huang Q, Huh J, Ai W, Ponzoni M, Ferreri AJ, Zhao X, Winter JN, Zhang M, Li L, Møller MB, Piris MA, Li Y, Go RS, Wu L, Medeiros LJ, Young KH. CD30 expression defines a novel subset of diffuse large B-cell lymphoma with favorable prognosis and distinct gene expression signature: a report from The International DLBCL Rituximab-CHOP consortium Program Study. Blood 121:2715-2724, 2013. e-Pub 2013. PMID: 23343832.
  85. Hoeller S, Zhou Y, Kanagal-Shamanna R, Xu-Monette ZY, Hoehn D, Bihl M, Swerdlow SH, Rosenwald A, Ott G, Said J, Dunphy CH, Bueso-Ramos CE, Lin P, Wang M, Miranda RN, Tzankov A, Medeiros LJ, Young KH. Composite mantle cell lymphoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: a clinicopathologic and molecular study. Hum Pathol 44:110-21, 2013. PMID: 22944294.
  86. Visco C, Tzankov A, Xu-Monette ZY, Miranda RN, Tai YC, Li Y, Liu WM, d'Amore ES, Li Y, Montes-Moreno S, Dybkær K, Chiu A, Orazi A, Zu Y, Bhagat G, Wang HY, Dunphy CH, His ED, Zhao XF, Choi WW, Zhao X, van Krieken JH, Huang Q, Ai W, O'Neill S, Ponzoni M, Ferreri AJ, Kahl BS, Winter JN, Go RS, Dirnhofer S, Piris MA, Møller MB, Wu L, Medeiros LJ, Young KH. Patients with diffuse large B cell lymphoma of germinal center origin with BCL2 translocations have poor outcome, irrespective of MYC status: a report from an International DLBCL rituximab-CHOP Consortium Program Study. Haematologica 98:255-263, 2013. PMID: 22929980.
  87. Al-Ibraheemi A, Kanagal-Shamanna R, Patel KP, Konoplev SN, Mehta P, Medeiros LJ, Miranda RN. Phenotypic evolution in a case of peripheral T-cell lymphoma suggests the presence of tumor heterogeneity. J Cutan Pathol 40:573-9, 2013. PMID: 23495765.
  88. Hu S, Xu-Monette ZY, Tzankov A, Green T, Wu L, Balasubramanyam A, Liu WM, Visco C, Li Y, Miranda RN, Montes-Moreno S, Dybkær K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Choi WW, Zhao X, van Krieken JH, Huang Q, Huh J, Ai W, Ponzoni M, Ferreri AJ, Zhou F, Slack GW, Gascoyne RD, Tu M, Variakojis D, Chen W, Go RS, Piris MA, Møller MB, Medeiros LJ, Young KH. MYC/BCL2 protein co-expression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program Study. Blood 121:4021-4031, 2013. PMID: 23449635.
  89. Jaso MJ, Yin CC, Wang SA, Miranda RN, Jabcuga CE, Chen L, Medeiros LJ.. Clinicopathologic Features of CD5-Positive Nodal Marginal Zone Lymphoma. Am J Clin Pathol 140:693-700, 2013.
  90. Loo EY, Medeiros LJ, Aladily TN, Hoehn D, Kanagal-Shamanna R, Young KH, Lin P, Bueso-Ramos CE, Manning JT Jr, Patel K, Thomazy V, Brynes RK, Goswami M, Fayad LE, Miranda RN.. Classical hodgkin lymphoma arising in the setting of iatrogenic immunodeficiency: a clinicopathologic study of 10 cases. Am J Surg Pathol 37:1290-7, 2013.
  91. Beltran BE, Quiñones P, Morales D, Alva JC, Miranda RN, Lu G, Shah BD, Sotomayor EM, Castillo JJ.. Follicular lymphoma with leukemic phase at diagnosis: A series of seven cases and review of the literature. Leuk Res 37:1116-9, 2013.
  92. Hu S, Bueso-Ramos CE, Verstovsek S, Miranda RN, Yin CC, McDonnell T, Medeiros LJ, Lin P.. Metastatic Splenic Angiosarcoma Presenting With Thrombocytopenia and Bone Marrow Fibrosis Mimicking Idiopathic Thrombocytopenic Purpura and Primary Myelofibrosis: A Diagnostic Challenge. Clin Lymphoma Myeloma Leuk 13:629-33, 2013. PMID: 23800601.
  93. Wang SA, Hutchinson L, Tang G, Chen SS, Miron PP, Huh YO, Jones DM, Bueso-Ramos C, Verstovsek S, Medeiros LJ, Miranda RN.. Systemic mastocytosis with associated clonal hematological non-mast cell lineage disease: Clinical significance and comparison of chromosomal abnormalities in SM and AHNMD components. Am J Hematol 88:219-24, 2013. PMID: 23335446.
  94. Kanagal-Shamanna R, Yin CC, Miranda RN, Bueso-Ramos CE, Wang XI, Muddasani R, Medeiros LJ, Lu G.. Therapy-related myeloid neoplasms with isolated del(20q): comparison with cases of de novo myelodysplastic syndrome with del (20q). Cancer Genet 206:42-46, 2013. PMID: 23357231.
  95. Kanagal-Shamanna R, Medeiros LJ, Lu G, Wang SA, Manning JT, Lin P, Penn GM, Young KH, You MJ, Vega F, Bassett R, Miranda RN. High-grade B cell lymphoma, unclassifiable, with blastoid features: an unusual morphological subgroup associated frequently with BCL2 and/or MYC gene rearrangements and a poor prognosis. Histopathology 61:945-54, 2012. e-Pub 2012. PMID: 22804688.
  96. Castillo JJ, Furman M, Beltrán BE, Bibas M, Bower M, Chen W, Díez-Martín JL, Liu JJ, Miranda RN, Montoto S, Nanaji NM, Navarro JT, Seegmiller AC, Vose JM. Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy. Cancer 118:5270-7, 2012. e-Pub 2012. PMID: 22510767.
  97. Visco C, Li Y, Xu-Monette ZY, Miranda RN, Green TM, Li Y, Tzankov A, Wen W, Liu WM, Kahl BS, d'Amore ES, Montes-Moreno S, Dybkær K, Chiu A, Tam W, Orazi A, Zu Y, Bhagat G, Winter JN, Wang HY, O'Neill S, Dunphy CH, Hsi ED, Zhao XF, Go RS, Choi WW, Zhou F, Czader M, Tong J, Zhao X, van Krieken JH, Huang Q, Ai W, Etzell J, Ponzoni M, Ferreri AJ, Piris MA, Møller MB, Bueso-Ramos CE, Medeiros LJ, Wu L, Young KH. Comprehensive gene expression profiling and immunohistochemical studies support application of immunophenotypic algorithm for molecular subtype classification in diffuse large B-cell lymphoma: a report from the International DLBCL Rituximab-CHOP Consortium Program Study. Leukemia 26:2103-13, 2012. e-Pub 2012. PMID: 22437443.
  98. Kiel MJ, Velusamy T, Betz BL, Zhao L, Weigelin HG, Chiang MY, Huebner-Chan DR, Bailey NG, Yang DT, Bhagat G, Miranda RN, Bahler DW, Medeiros LJ, Lim MS, Elenitoba-Johnson KS. Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma. J Exp Med 209:1553-65, 2012. e-Pub 2012. PMID: 22891276.
  99. Aladily TN, Medeiros LJ, Amin MB, Haideri N, Ye D, Azevedo SJ, Jorgensen JL, de Peralta-Venturina M, Mustafa EB, Young KH, You MJ, Fayad LE, Blenc AM, Miranda RN. Anaplastic large cell lymphoma associated with breast implants: a report of 13 cases. Am J Surg Pathol 36(7):1000-1008, 2012. PMID: 22613996.
  100. Yang Q, Chen LS, Neelapu SS, Miranda RN, Medeiros LJ, Gandhi V. Transcription and translation are primary targets of Pim kinase inhibitor, SGI-1776, in mantle cell lymphoma. Blood 120:3491-3500, 2012. PMID: 22955922.
  101. Xu-Monette ZY, Wu L, Visco C, Tai YC, Tzankov A, Liu WM, Montes-Moreno S, Dybkaer K, Chiu A, Orazi A, Zu Y, Bhagat G, Richards KL, Hsi ED, Zhao XF, Choi WW, Zhao X, van Krieken JH, Huang Q, Huh J, Ai W, Ponzoni MA, Ferreri AJ, Zhou F, Kahl BS, Winter JN, Xu W, Li J, Go RS, Li Y, Piris MA, Moller MB, Miranda RN, Abruzzo LV, Medeiros LJ, Young KH. Mutational profile and prognostic significance of TP53 in diffuse large B-cell lymphoma patients treated with rituximab-CHOP: a report from an International DLBCL Rituximab-CHOP Consortium Program study. Blood 120:3986-96, 2012. PMID: 22955915.
  102. Caponetti GC, Miranda RN, Althof PA, Dobesh RC, Sanger WG, Medeiros LJ, Greiner TC, Weisenburger DD. Immunohistochemical and molecular cytogenetic evaluation of potential targets for tyrosine kinase inhibitors in Langerhans cell histiocytosis. Hum Pathol 43:2223-8, 2012. PMID: 22748304.
  103. Hoehn D, Miranda RN, Kanagal-Shamanna R, Lin P, Medeiros LJ. Splenic B-cell lymphoma with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation. Hum Pathol 43:1828-1838, 2012. PMID: 22520947.
  104. Jaso J, Chen L, Li S, Lin P, Chen W, Miranda RN, Konoplev S, Medeiros LJ, Yin CC. CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma: a clinicopathologic study of 14 cases. Hum Pathol 43:1436-43, 2012. PMID: 22406370.
  105. Li S, Lin P, Fayad LE, Lennon PA, Miranda RN, Yin CC, Lin E, Medeiros LJ. B-cell lymphomas with MYC/8q24 rearrangements and [email protected]/t(14;18)(q32;q21): an aggressive disease with heterogeneous histology, germinal center B-cell immunophenotype and poor outcome. Mod Pathol 25:145-56, 2012. PMID: 22002575.
  106. Aladily TN, Nathwani BN, Miranda RN, Kansal R, Yin CC, Protzel R, Takowsky GS, Medeiros LJ.. Extranodal NK/T-cell lymphoma, nasal type, arising in association with saline breast implant: expanding the spectrum of breast implant-associated lymphomas. Am J Surg Pathol 36:1729-34, 2012. PMID: 23073330.
  107. Wang SA, Abruzzo LV, Hasserjian RP, Zhang L, Hu Y, Galili N, Raza A, Garcia-Manero G, Medeiros LJ, Miranda RN. Myelodysplastic syndromes with deletions of 11q lack cryptic MLL rearrangement and exhibit characteristic clinicopathologic features. Leuk Res 35:351, 2011.
  108. Lin P, Dickason TJ, Fayad LE, Lennon PA, Hu P, Routbort MJ, Miranda RN, Wang X, Medeiros LJ. Prognostic value of MYC rearrangement in cases of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. Cancer 118:1566-73, 2011.
  109. Castillo JJ, Beltran BE, Miranda RN, Paydas S, Winer ES, Butera JN. Epstein-Bar Virus positive diffuse large B-cell lymphoma of the elderly: what we know so far. Oncologist 16:87-96, 2011.
  110. Beltran B, Castillo JJ, Morales D, Salas R, Quinones P, Miranda RN, Gallo A, Lopez M, Butera J, Sotomayor EM. EBV (+) diffuse large B cell lymphoma of the elderly: Report of 24 cases from South America. Am J Hematology 86:663-667, 2011.
  111. Liu W, Hasserjian RP, Hu Y, Zhang L, Miranda RN, Medeiros LJ, Wang SA. Pure erythroid leukemia: A reassessment of the entity using the 2008 World Health Organization classification. Mod Pathol 24:375-383, 2011.
  112. Drakos E, Leventaki V, Atsaves V, Schlette EJ, Lin P, Vega F, Miranda RN, Claret FX, Medeiros LJ, Rassidakis GZ. Expression of serine 194-phosphorylated Fas-associated death domain protein correlates with proliferation in B-cell non-Hodgkin lymphomas. Hum Pathol 42:1117-24, 2011. PMID: 21315423.
  113. Egwuonwu S, Gatto-Weis C, Miranda R, De Las Casas L.. Gastrointestinal Kaposi sarcoma with appendiceal involvement. South Med J 104:278-281, 2011.
  114. Beltran BE, Morales D, Quinones P, Medeiros LJ, Miranda RN, Castillo JJ. EBV-positive diffuse large B-cell lymphoma in young immunocompetent individuals. Clin Lymphoma Myeloma Leuk 11:512-6, 2011.
  115. Vigil CE, Wang SA, Cortes JE, Bueso-Ramos C, Verstovsek S, Shinder R, Chen SS, Katz RL, Khanna A, Esmaeli B, Manning JT, You MJ, Miranda RN. Dasatinib-responsive mast cell neoplasms as initial presentation of chronic myelogenous leukemia in blast phase. J Clin Oncol 10:514-6, 2011.
  116. Klysik M, Gavito JH, Boman D, Miranda RN, Hanbali F, De Las Casas LE. Intraoperative imprint cytology of central neurocytoma: The great oligodendroglioma mimicker. Diagn Cytopathol 38:202-207, 2010.
  117. Liang M, Han X, Nguyen M, Fernandez M, Drakos E, Konoplev SN, Miranda RN, Yin CC, Medeiros LJ, Bueso-Ramos CE. HDM 4 is overexpresed in mantle cell lymphoma and its inhibition induces P21 expression and apoptosis. Mod Pathol 23:381-391, 2010.
  118. Jackson CC, Medeiros LJ, Miranda RN. The 8p11 Myeloproliferative Syndrome. A review. Hum Pathol 41:461-476, 2010.
  119. Liu Y, Li L, Hu Q, Miranda RN. Inflammatory pseudotumor-like follicular dendritic cell tumor of the liver with expression of estrogen receptor suggests a pathogenic mechanism: a case report and review of the literature. J Hematopathol 3:109-115, 2010.
  120. Kasyan A, Medeiros LJ, Zuo Z, Santos FP, Ravandi-Kashani F, Miranda RN, Vadhan-Raj S, Koeppen H, Bueso-Ramos CE.. Acute erythroid leukemia as defined in the World Health Organization classification is a rare and pathogenetically heterogeneous disease. Mod Pathol 23:1113-1126, 2010.
  121. Beltran BE, Morales D, Quinones P, Miranda RN, Goswami M, Castillo JJ. Peripheral T-cell lymphoma with a regulatory T-cell phenotype: Report of a nodal and an extranodal case from Peru. Appl Immunohistochem Mol Morphol 20:196-200, 2010.
  122. De Las Casas L, Morales A, Boman D, Tyroch A, Calleros-Macias J, Miranda RN. Laparoscopic Aspiration Cytology in Rheumatoid Ascites. Acta Cytologica 54:1123, 2010.
  123. DePond W, Kure K, Lankachandra K,Gidwani R, Nelson Brook, Zimmerman H,Talboy GE, Miranda RN. Human Papillomavirus-58 and -73 Associated Digital Squamoous Cell Carcinoma in a patient with Aggressive Digital Papillary Adenocarcinoma. Am J Dermatopathol 31:375-378, 2009.
  124. Miranda RN, Lin L, Talwalkar SS, Manning JT, Medeiros LJ.. Anaplastic large cell lymphoma involving the breast: a clinicopathologic study of six cases and review of the literature. Arch Pathol Lab Med 133:1383-1390, 2009.
  125. Huh YO, Medeiros LJ, Ravandi F, Konoplev S, Jorgensen JL, Miranda RN.. T-cell large granular lymphocyte leukemia associated with myelodysplastic syndrome: A clinicopathologic study of 9 cases. Am J Clin Pathol(131):347-356, 2009.
  126. Talwalkar SS, Miranda RN, Valbuena JR, Routbort MJ, Martin AW, Medeiros LJ. Lymphomas involving the breast: a study of 106 cases comparing localized and disseminated neoplasms. Am J Surg Pathol 32:1299-1309, 2008. PMID: 18636016.
  127. Badr MZ, Shnyra A, Zoubine M, Norkin M, Herndon B, Quinn T, Miranda RN, Cunningham ML, Molteni A. Phthalate-induced liver protection against deleterious effects of Th1 response: A potentially serious health hazard?. PPAR Research:49671, 2007.
  128. Dim DC, Cooley LD, Miranda RN. Clear cell sarcoma of tendons and aponeuroses: a review. Arch Pathol Lab Med 131:152-6, 2007. PMID: 17227118.
  129. Miranda RN, Omurtag K, Castellani WJ, De Las Casas LE, Quintanilla NM, Kaabipour E. Myelopoiesis in the liver of stillborns with evidence of intrauterine infection. Arch Pathol Lab Med 130:1786-91, 2006.
  130. De Las Casas LE, Mrak R, Miranda RN. Fine needle aspiration biopsy findings of adrenal cortical carcinoma. ASCP Check Sample C 05-5 (C0371). Cytopathology 33:69-83, 2005.
  131. De Las Casas LE, Odle JL, Miranda RN. Fine needle aspiration biopsy findings of metastatic clear cell hepatocellular carcinoma. ASCP Check Sample C05-9 (C-375). Cytopathology 33:135-50, 2005.
  132. Briggs RC, Atkinson JB, Miranda RN. Variable expression of myeloid cell specific nuclear antigen MNDA in monocyte lineage cells in atherosclerosis. J Cell Biochem 95:293-301, 2005.
  133. Oba Y, Salzman GA, Miranda RN. Pulmonary blastoma. J Bronchol 11:198-99, 2004.
  134. De Las Casas LE, Gokden M, Baker SJ, Korourian S, Hermonat PL, You H, Miranda RN, Shalkham JE, O'Brien LA, Mukunyadzi P. Malignant melanoma metastatic to the liver. A cytomorphologic comparative study to identify reproducible diagnostic criteria. Acta Cytol 48:32-8, 2004. PMID: 14969178.
  135. De Las Casas LE, Gokden M, Mukunyadzi P, White P, Baker SJ, Hermonat PL, You H, Korourian S, Malak SF, Miranda RN. A morphologic and statistical comparative study of small-cell carcinoma and non-Hodgkin's lymphoma in fine-needle aspiration biopsy material from lymph nodes. Diagn Cytopathol 31:229-34, 2004. PMID: 15452900.
  136. Weiner MF, Miranda RN, Bardales RH, Mukunyadzi P, Baker SJ, Korourian S, De Las Casas LE. Diagnostic value of GLUT-1 immunoreactivity to distinguish benign from malignant cystic squamous lesions of the head and neck in fine-needle aspiration biopsy material. Diagn Cytopathol 31:294-9, 2004. PMID: 15468132.
  137. McArthur CP, Africa CW, Castellani WJ, Luangjamekorn NJ, McLaughlin M, Subtil-DeOliveira A, Cobb C, Howard P, Gustafson S, Palmer D, Miranda RN. Salivary gland disease in HIV/AIDS and primary Sjögren's syndrome: analysis of collagen I distribution and histopathology in American and African patients. J Oral Pathol Med 32:544-51, 2003. PMID: 12969229.
  138. Quddus M, Latkovich P, Castellani WJ, Sung C, Steinhoff MM, Briggs RC, Miranda RN. Expression of cyclin D1 in normal, metaplastic, hyperplastic endometrium and endometrioid carcinoma suggests a role in endometrial carcinogenesis. Arch Pathol Lab Med 126:459-63, 2002. PMID: 11900573.
  139. Rosales CM, McLaughlin MD, Sata T, Katano H, Veno PA, de Las Casas LE, Miranda RN. AIDS presenting with cutaneous Kaposi's sarcoma and bacillary angiomatosis in the bone marrow mimicking Kaposi's sarcoma. AIDS Patient Care STDS 16:573-7, 2002. PMID: 12542930.
  140. Brewington R, Chatterji M, Zoubine M, Miranda RN, Norimatsu M, Shnyra A. Ifn-gamma-independent autocrine cytokine regulatory mechanism in reprogramming of macrophage responses to bacterial lipopolysaccharide. J Immunol 167:392-98, 2001.
  141. McArthur CP, Subtil A, Palmer D, Fiorella RM, Gustafson S, Tira D, Miranda RN. Characteristics of salivary diffuse infiltrative lymphocytosis syndrome (DILS) in West Africa: HIV-associated salivary ductal epithelial atypia?. Arch Pathol Lab Med 124:1773-79, 2000.
  142. Miranda RN, Briggs RC, Kinney MC, Veno PA, Hammer RD, Cousar JB. Immunohistochemical detection of cyclin D1 using optimized conditions is highly specific for mantle cell lymphoma and hairy cell leukemia. Modern Pathology 13:1308-14, 2000.
  143. Miranda RN, Cousar JB, Hammer RD, Collins RD, Vnencak-Jones CL. Somatic mutation analysis of IgH variable regions reveals that tumor cells of most parafollicular (monocytoid) B-cell lymphoma, splenic marginal zone B-cell lymphoma, and some hairy cell leukemia are composed of memory B lymphocytes. Hum Pathol 30:306-12, 1999.
  144. Miranda RN, Briggs RC, Shults K, Kinney MC, Jensen RA, Cousar JB. Immunocytochemical analysis of MNDA in tissue sections and sorted normal bone marrow cells documents expression only in maturing normal and neoplastic myelomonocytic cells and a subset of normal and neoplastic B lymphocytes. Hum Pathol 30:1040-49, 1999.
  145. Tucker TJ, Bardales RH, Miranda RN. Intravascular lymphomatosis with bone marrow involvement. Arch Pathol Lab Med 123:952-6, 1999. PMID: 10506453.
  146. Miranda RN, McMillan PN, Pricolo VE, Finkelstein SD. Peritoneal silicosis. Arch Pathol Lab Med 120:300-302, 1996.
  147. Miranda RN, Glantz L, Myint MA, Levy N, Jackson CL, Rhodes CH, Glantz MJ, Medeiros LJ. Stage IE non-Hodgkin’s lymphoma involving the dura. A clinicopathologic study of five patients. Arch Pathol Lab Med 120:254-60, 1996.
  148. Bacchi MM, Bacchi CE, Alvarenga M, Miranda RN, Chen YY, Weiss LM. Burkitt's lymphoma in Brazil: Strong association with Epstein-Barr virus. Modern Pathology 9:63-67, 1996.
  149. Wu CD, Medeiros LJ, Miranda RN, Mark HFL, Rintels P. Chronic myeloid leukemia manifested during megakaryoblastic crisis. South Med J 89:422-27, 1996.
  150. Evans RI, Miranda RN, Jordan J, Krolikowski FJ. Fatal acute pancreatitis caused by valproic acid. Am J Forensic Pathol 16:62-65, 1995.
  151. Miranda RN, Wu CD, Nayak RN, Kragel PJ, Medeiros LJ. Amyloid in adrenal gland pheochromocytomas. Arch Pathol Lab Med 119:827-30, 1995.
  152. Miranda RN, Myint MA, Gnepp DR. Composite follicular variant of papillary carcinoma and mucoepidermoid carcinoma of the thyroid. Report of a case and review of the literature. Am J Surg Pathol 19:1209-15, 1995.
  153. Miranda RN, Esparza AR, Sambandam S, Medeiros LJ. Systemic mast cell disease presenting with peripheral blood eosinophilia. Hum Pathol 25:727-30, 1994.
  154. Krolikowski FJ, Evans R, Lauro G, Katsis G, Miranda RN. A shocking case. Check Sample. American Society of Clinical Pathologists 36:77-85, 1994.
  155. Miranda RN, Mark HFL, Medeiros LJ. Fluorescent in situ hybridization in routinely processed bone marrow specimen. Am J Pathol 145:1309-14, 1994.
  156. Miranda, RN. Primary liver carcinoma: Clinicopathologic study. Bachelor in Medicine Thesis, 1988.
  157. Miranda, RN. Histopathology of gastric biopsies in Cayetano Heredia Hospital. Pathology Specialist Thesis, 1983.
  158. Karuturi M, Younes A, Fayad L, Kwak L, Pro B, Shah J, Oki Y, Simien R, Liboon MJ, Hutto T, Feng L, Horowitz S, Nieto Y, Anderlini P, Alousi A, Popat U, Medeiros LJ, Miranda R, Fanale M. Ifosfamide, carboplatin, etoposide with or without bortezomib in patients with relapsed/refractory Hodgkin lymphoma: results of a randomized phase II trial. Leuk Lymphoma:1-3. e-Pub 2015. PMID: 25804933.
  159. Jour G, Aung PP, Merrill ED, Curry JL, Tetzlaff MT, Nagarajan P, Ivan D, Prieto VG, Duvic M, Miranda RN, Torres-Cabala CA. Differential expression of CCR4 in primary cutaneous gamma/delta (γ/δ) T cell lymphomas and mycosis fungoides: Significance for diagnosis and therapy. J Dermatol Sci. e-Pub 2018. PMID: 29030090.

Letters to the Editor

  1. Clemens MW, Miranda RN. Commentary on: CD30+ T Cells in Late Seroma May Not Be Diagnostic of Breast Implant-Associated Anaplastic Large Cell Lymphoma. Aesthet Surg J 37: 776-778, 2017.

Read More


Whether you are ready to make an appointment now or have questions for our expert team, we are standing by to help.

Learn more

Our patients have access to clinical trials offering promising new treatments that cannot be found anywhere else.

Learn more

Sours: https://faculty.mdanderson.org/profiles/roberto_miranda.html
  1. Francis chan revelation
  2. Stream labs.com
  3. Throggs neck pharmacy
  4. Nissan versa note 2014 transmission

Board Certification

  • Board Certified Surgeon
    General – Breast Surgery



Fairview Hospital – Cleveland Clinic.
Cleveland, OH


Maimonides Medical Center
Brooklyn, NY

Medical School

University of Guayaquil, Medical School
Guayaquil -Ecuador

Hospitals Affiliated With

  • Methodist Willowbrook
  • CHI St. Lukes The Woodlands
  • CHI Springwoods St. Lukes Hospital
  • HCA Healthcare Houston Northwest
  • St. Joseph Hospital
  • East Houston Hospital and Clinics
  • HCA Healthcare Southeast

Professional Associations

American College of Surgeons
American Society of Breast Surgeons
Hispanic American Medical Association of Houston/Past President

Academic Appointments

  • Assistant Professor of Surgery at Texas Tech University Health Sciences Center. 2004-2009
  • Clinical Assistant Professor at Texas Tech University Health Sciences Center / School of Allied Health Sciences, Physician Assistant Program. 2007-2009
  • Academic Appointment at University of North Texas Health Sciences Center at Fort Worth. 2007-2012

Personal Interests

In his free time, Dr. Miranda enjoys listening to Classical Music, jogging and swimming and is interested in sport cars.


Leonidas Miranda, MD, is a board certified general surgeon who has been practicing medicine for 31 years. He received his medical degree from the University of Guayaquil in Guayaquil, Ecuador and completed his residency in General Surgery at the Cleveland Clinic Health System in Cleveland, Ohio. He then completed 5 successful years as an assistant professor of Surgery at Texas Tech University before coming to Houston in 2009. Dr. Miranda is also a member of the American Society of Breast Surgeons (ASBrS) and is a Fellow of the American College of Surgeons (FACS).

He specializes in a wide variety of procedures, including hernias, gallbladder disease, gastrointestinal problems, tumors of the skin/soft tissues, and placement of venous access ports for chemotherapy. In addition to general surgery, he has a clinical expertise and special focus in the management of benign and malignant breast diseases.

Dr. Miranda is greatly involved in all aspects of managing surgical procedures – focusing on the management of his patients from the preoperative visit, to the maintenance of pain control and nutrition postoperatively. He is a compassionate physician who constantly coordinates with referring physicians and specialists, including medical oncologists, radiation oncologists, and plastic surgeons to ensure the utmost care for his patients.

He provides safe and modern techniques for his patients by using state of the art surgical breast procedures, such as breast conservation with oncoplastic surgery and lymphedema prevention techniques for the surgical treatment of breast cancer. Additionally, Dr. Miranda has special training in wound care, which allows him to be very meticulous when it comes to plastic surgery techniques for skin closure resulting in minimal or no visible scars.

Dr. Miranda grew up in Ecuador as the oldest child of four and comes from a family with many physicians. As a child, he was inspired by his family and his own calling to help people, so he decided to pursue a career in medicine. In fact, he graduated top of his medical school class and was motivated to continue his dream of becoming a surgeon here in the United States. When he isn’t at work, he loves spending time with his wife, daughter, and playful miniature poodle. He also enjoys engaging in one of his many hobbies, such as playing the piano, jogging, and reading about the latest updates in the car industry.

Dr. Miranda is fluent in Spanish and is accepting new patients.

Sours: https://www.houstonelitesurgicalcare.com/doctors/dr-leonidas-miranda/
Dr. Miranda


Miranda tx dr houston


Dying in the Name of Vaccine Freedom - NYT Opinion


Similar news:


2295 2296 2297 2298 2299